Tag: cell pouch

May 8, 2018

Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator

Sernova (TSX-V:SVA)  announces Dr. Piotr Witkowski, M.D., Ph.D., a leading expert in type 1 diabetes (T1D) and islet transplantation, as...
July 24, 2017

Sernova Announces Progress in Development of Regenerative Medicine Therapy

Sernova announced an update for its personalized regenerative medicine therapy for the treatment of Hemophilia A patients.
April 24, 2017

4 Top Life Science Stocks on the TSX Venture 50

A look at the top life science stocks on the TSXV Top 50 Companies.
November 2, 2016

Sernova Announces Regulatory Collaboration with CTI Clinical Trial and Consulting Services

Sernova Corp. today announces a regulatory collaboration with CTI Clinical Trial and Consulting Services on Sernova's Cell Pouch System.
June 27, 2016

Sernova Announces $2,000,000 First Closing of Private Placement

LONDON, ONTARIO–(Marketwired – June 27, 2016) – Sernova Corp. (“Sernova” or the “Company”) (TSX VENTURE:SVA)(OTCQB:SEOVF)(FRANKFURT:PSH) is pleased to announce that...
January 26, 2016

Sernova Announces Agreement With CCRM to Produce Specialized Cells for the Treatment of Diabetes

Sernova Corp. (TSXV:SVA, FWB:PSH, OTCQB:SEOVF) entered into a service agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to...
September 11, 2015

Sernova Signs Licence Agreement with the UNH of Toronto

Sernova (TSX-V:SVA) (FSE:PSH) has announced a licence agreement with the University Health Nework of Toronto, securing worldwide commercial rights to...